'Dangerous Drugs' Category
By Trent B. Miracle | July 14, 2014
New FDA Warning Against Use of Numbing Medications in Infants
Parents with teething infants should not use “gum-numbing” anesthetics known as viscous lidocaine, the U.S. Food and Drug Administration (FDA) recently reported. When used among infants and young children, such medications can… Read More
By Trent B. Miracle | June 23, 2014
New Risk of Blood Clots Associated with Testosterone Treatments
The US Food and Drug Administration (FDA), announced last week that there has been another risk associated with testosterone treatments. The FDA is now requiring manufacturers of testosterone or low T products must… Read More
By Trent B. Miracle | June 11, 2014
Testosterone Therapy Lawsuits Consolidated Before One Judge
The U.S. Judicial Panel on Multidistrict Litigation has ordered the consolidation of all federal testosterone therapy lawsuits before the Hon. Matthew F. Kennelly in the Northern District of Illinois, U.S. District Court.… Read More
By Simmons Hanly Conroy | June 10, 2014
Testosterone Therapy Lawsuits Consolidated Before One Judge
The U.S. Judicial Panel on Multidistrict Litigation has ordered the consolidation of all federal testosterone therapy lawsuits before the Hon. Matthew F. Kennelly in the Northern District of Illinois, U.S. District Court.… Read More
By Trent B. Miracle | May 7, 2014
FDA Moves Transvaginal Mesh Devices to ‘High Risk’ Category
The U.S. Food and Drug Administration recently submitted a federal proposal to establish stricter safety requirements for transvaginal surgical mesh implants. The devices are often used to repair pelvic collapse in women, and… Read More
By Amy Fair | April 22, 2014
The Psychological Effects of Gynecomastia Linked to Risperdal
A study conducted by the American Society of Plastic Surgeons (ASPS) and colleagues of Boston Children’s Hospital examined the mental and emotional effects of gynecomastia, a condition in which men develop female… Read More
By Amy Fair | April 16, 2014
Low Testosterone Diagnosis: Are Current Testing Methods Substantial?
Since 2000, the number of American men taking testosterone replacement therapy has quadrupled. More than 5 million prescriptions were written for testosterone therapy in 2011 alone. Men experience a decline in natural… Read More
By Trent B. Miracle | April 16, 2014
Louisiana Jury Orders Actos Manufacturer to Pay $9 Billion
Takeda Pharmaceutical Co. and Eli Lilly & Co. have been ordered to pay a total of $9 billion in punitive damages in connection to the diabetes drug Actos. A Louisiana jury found… Read More
By Trent B. Miracle | March 14, 2014
Consolidation of Lipitor Lawsuits to Streamline Process
Currently 56 personal injury claims regarding Lipitor have been filed. More than 170 similar federal cases are pending in more than 40 districts before 100 different judges. As a result, the U.S.… Read More
By Michael J. Angelides | March 7, 2014
FDA Runs First Widespread Quality & Safety Evaluation on Generic Drugs
More than 80 percent of prescription drugs in the U.S. are being tested by the Food and Drug Administration (FDA) in its first widespread safety and quality evaluation. The effort will examine… Read More
